CMA Foundation
About Us Projects Publications What's New Events Donate to the Foundation Calendar Links

1. Obesity Provider Toolkits Now Available
2. AWARE Launches New Website dot
3. Improving Diabetes Quality Care dots
4. Nominate an Outstanding Individual or Organization for 2008 Leadership Awards
5. Become a Friend of the Foundation
6. Symposium Brings Experts Together to Develop CA-MRSA Statewide Plan dots
7. County Corner: San Francisco County Medical Society
8. Corporate Advisor Spotlight: Genentech dot
9. Development Director Joins Foundation
10. Thank you to Our Generous Donors

1. Obesity Provider Toolkits Now Available

The CMA Foundation and the California Association of Health Plans have released the first-ever comprehensive set of obesity provider toolkits designed to help doctors assist their patients in weight management and obesity prevention.

The Adult, Child and Adolescent, and Pre/Post-Bariatric Surgery toolkits have been developed by physicians and other medical experts to encourage and foster discussion between physicians and their patients about obesity to improve care and outcomes.

“Surveys of physicians have indicated that many do not feel they have the required resources and skills to assist those who they identify in need of achieving a healthy weight,” said Seleda Williams, MD, MPH, PHMO III, a member of the expert panel that developed the adult toolkit.  “These toolkits provide some of those tools, including basic elements of office management and patient educational resources.  Achieving a healthy weight leads to additional patient benefits such achieving optimal heart health and reduced risks for other related chronic disease risks.”

Click here to view and download all toolkits.

Back to Top

2. AWARE Launches New Website

The CMA Foundation is pleased to announce the launch of an all-new AWARE website at

The new site features the latest information about appropriate antibiotic use and related topics for patients and providers. An all-new CA-MRSA section features a comprehensive collection of resources and best practices specifically geared toward medical professionals, athletes, childcare providers, schools and work places.

“All of the tools that AWARE has developed for clinicians and patients are easy to find and download on the new website, which is really convenient,” said Joe Toscano, MD, attending emergency physician at San Ramon Regional Medical Center.  “With the new format of the site, it’s even easier to navigate and find what you need. The site also contains a lot of great information about the organization, its history, mission, and goals.”

Topics available for patients and consumers include frequently asked questions about bacteria and how to stay healthy during cold and flu season, antibiotic facts, vaccine information, and childcare provider resources. Health care professionals will find valuable information on clinical resources, surveillance data and resources, continuing education programs, and more.

Back to TOp

3. Improving Diabetes Quality Care

Advancing Practice Excellence in Diabetes continues pilot projects in San Joaquin County, the Inland Empire, and Butte/Glenn County regions where a total of 23 practices actively participate in the quality improvement project.

For the past two years, project staff has worked with physicians, medical assistants and office staff in all participating practices to develop tools and strategies for improving care given to patients with diabetes. Family care physicians Jared Garrison, DO and Mark Garrison, DO have been involved in the project since its start in 2006, and have helped the Foundation tailor and grow the project to become an effective model for diabetes care improvement.

“I believe that as a primary care physician, there is little we can do that has a bigger impact on our patients than to properly manage diabetes mellitus and its comorbidities,” Dr. Jared Garrison said of the practice’s passion for improving diabetes care.

Throughout their participation in the project, the Garrison practice has embraced the underlying concepts behind the team care approach by promoting improved physician and staff communications. Quality care improvement steps adopted by the practice include identifying diabetic patients using chart stickers, organizing regular staff meetings to promote communication, conducting foot exams during every diabetic patient visit, and regularly updating patient data in DocSite—a disease registry system.

“Our project staff has learned a lot from working with the Garrison practice,” said Allyn Davis, Director of the Diabetes Project. “We’ve learned that physicians must be on board if any quality improvements are to be accomplished, and that a strong staff champion is necessary to motivate and educate medical office staff about the importance of diabetes care and the need for improvement. We’ve also learned that quality improvement changes don’t happen overnight—it takes time, commitment, and small progressive steps toward change.”

Click here to learn more about Advancing Practice Excellence in Diabetes.

Back to Top

4. Nominate an Outstanding Individual or Organization for 2008 Leadership Awards

Award season at the CMA Foundation is rapidly approaching, meaning you will soon see requests for leadership award nominations in your mailbox. Recognizing outstanding leaders in the health care profession is a priority for the Foundation, and your nomination is vital to ensure that California’s most exceptional individuals and organizations are honored.

The Foundation’s leadership awards are designed to recognize a range of leaders who make outstanding contributions to the health of their communities in various ways:

Ethnic Physician Leadership Award: The Foundation’s Network of Ethnic Physician Organizations (NEPO) honors an ethnic physician for his or her outstanding leadership contributions to ethnic communities.  The purpose of the award is to honor an individual, inspire others, and promote leadership, caring and compassion in medicine.

Award recipients are those that have contributed greatly to the public’s health and embody NEPO’s goals to advance diversity in the physician workforce, eliminate health disparities, address access to care, and improve cultural competency and patient advocacy. The award consists of a plaque and expenses for the honoree to attend the awards ceremony at the Annual NEPO Summit.

Robert D. Sparks, MD Leadership Achievement Award: The award was established in 1997 in honor of Dr. Sparks, the first CMA Foundation President & CEO.The award is given to an individual or organization that has made extraordinary efforts and significant contributions toward making positive change in health issues that affect the greater community. Leadership award recipients have demonstrated outstanding concern for the health of their communities in a manner consistent with the CMA Foundation’s mission.

The award consists of a $1,000 stipend, plaque and expenses for the honoree to attend the awards ceremony at the Annual Leadership Dinner.

Adarsh S. Mahal, MD Access to Health Care and Disparities Award: This award was established in 2007 by past CMA President Anmol S. Mahal, MD and his wife Surjit K. Mahal, MD. The award honors an individual or organization that has made extraordinary efforts and significant contributions toward improving access to health care or reducing health care disparities in California consistent with the mission of the CMA Foundation.

This award also consists of a $1,000 stipend, plaque and expenses for the honoree to attend the awards ceremony at the Annual Leadership Dinner.

Help us recognize California’s health leaders by nominating and outstanding individual or organization in your community. Nomination information will be sent to all CMA Foundation supporters in the coming month. For more information, contact Carol Lee at 916.551.2562.

Back to top

Become a Friend of the Foundation

I’m sure you know that The California Medical Association Foundation delivers ground-breaking research and toolkits that help health care providers treat patients every day.

What you may not know is that the Foundation, a separate entity from the California Medical Association, receives no membership dues and relies completely on the generosity of supporters like you.

Our neutral stance uniquely positions us to convene diverse stakeholders to address the most pervasive health problems in the state. Through our collective wisdom we are addressing sensitive—yet very real—issues like obesity, diabetes, and cervical cancer.   Together we’re weaving a collective vision of what a true state of health for every Californian looks like. Our work crosses all boundaries. In fact, we see possibility where others see boundaries. At one of our recent summits, I heard a physician say to a health plan representative, in the company of three pharmaceutical executives, “this event brought us together, but the Foundation made us friends.”

Our ability to bring everyone together to solve problems depends on our ability to muster support from our friends throughout the state. We have arrived at this point of impact because of the relentless efforts of talented staff, combined with the generous support of a small but mighty segment of the philanthropic community, to whom we are deeply grateful!   

Today, more than ever, we need your help, and I ask you to consider making a renewed commitment to the Foundation.   Will you join me as a new Friend of the Foundation by making a tax-deductible gift of $100 or more to the Annual Fund?   We depend on the fund to meet operational needs and to support the development of our comprehensive materials.

Your support is invaluable!   Please use the attached envelope to return your gift today.

P.S. If you would like to make a major donation, or include the Foundation in your estate planning, please call me at 916.551.2547.

- Nicolette Bautista, Director of Development

back to top

5. Symposium Brings Experts Together to Develop CA-MRSA Statewide Plan of Action

The CMA Foundation’s AWARE Project convened a CA-MRSA Summit in February to develop the first comprehensive statewide plan of action for increasing awareness and prevention of CA-MRSA infections. The symposium brought together more than 60 representatives from medicine, public health, education, athletic programs, consumer advocates, and business to develop themes and specific strategies to be included in the plan.

The complexities of tracking and preventing further spread of CA-MRSA infections in California were illustrated during the symposium’s morning session. Mark Horton, MD, MSPH, Director of the California Department of Public Health, delivered the keynote message highlighting the state’s recent decision to make CA-MRSA a reportable disease; It is anticipated that this reporting will capture approximately 200 cases a year.

Breakout sessions in the afternoon allowed collaboration between representatives from each sector to promote synergy and foster partnerships.  Each group eagerly accepted the challenge to develop strategies for education, prevention, and CA-MRSA management for each designated population.  As questions arose, each group was equipped with the expertise to develop realistic action steps and develop collaborative responses. Key actions steps identified in the workgroups include: 

• The development of policy for schools and athletic programs pertaining to students and/or athletes  developing a CA-MRSA infection;

• Increasing resources available to diverse populations, employers, and private practice physicians;

• Engaging non-traditional partners in CA-MRSA prevention and developing effective messages to reach diverse sectors of California’s population;

• Increasing knowledge of CA-MRSA prevention among health care providers by developing clinical resources.

The finalized action plan will be sent to the Centers for Disease Control and Prevention this spring.  For more information on the CA-MRSA Plan of Action or the AWARE Project visit or contact or contact Cristina Correa, AWARE Project Director, at 916.551.2551.

Back to Top

County Corner: San Francisco Medical Society

More than 87,000 synthetic chemicals (and counting) are currently registered for use in the United States. Do you know what these chemicals are? Do you know that exposure to various chemical compounds can have profoundly negative effects on human health; or that the United States government currently has inadequate methods of protecting us from these effects?

Members of The Collaborative on Health and the Environment (CHE) know, and they’re taking great strides to see that these chemicals are appropriately tested for safety and efficacy before they are available for mainstream use.

CHE was formed in 2002 with help of founding partner organization San Francisco Medical Society (SFMS) to convene those with an interest in environmental health—particularly industrial chemical safety. CHE has more than 2,600 individual and 470 organizational partners worldwide that include practicing and research physicians, health care professionals,  concerned citizens, children’s environmental health organizations, government organizations and philanthropic organizations—to name a few.

“San Francisco Medical Society took a leading role in bringing together individuals and organizations that share a common interest and concern over chemical policy, but had not yet come together to talk,” said Steve Heilig, MPH, Director of Public Health & Education for CHE and SFMS.

At the 2007 CMA House of Delegates meeting, the policy A Modern Chemicals Policy for California and Beyond, authored by Lucy Crain, MD and Robert Gould, MD and initiated by SFMS delegation, was passed. The policy charges CMA with urging California and U.S. government to develop and implement “a state and national modern, comprehensive chemicals policy in line with current scientific knowledge on human health, and that requires a full evaluation of the health impacts of both newly developed and existing industrial chemicals now in use.”

“California is often a model for what happens nationally, so we’re leading the efforts here to ensure that there’s a system in place for testing chemicals before they’re put into mainstream use,” Heilig said. “We’re making sure that all policy recommendations are based on science and people are seeing that as a real contribution to this topic.”

According to CHE, the United States is so far behind Europe in industrial chemical policy, that many chemicals being used here are no longer allowed in Europe.

“We’ve now lagged so far behind, that even industry is pushing for chemical regulation,” Heilig said. “We are fighting for the development of a similar broad chemical policy that is based on known science. Taking the recently passed chemicals policy to the national level is very important.”

To learn more about industrial chemical policy or CHE, or for resources, facts and science information, visit

back to top

Corporate Advisor Spotlight: Genentech

Genentech is a biotechnology company specializing in using human genetic information to discover, develop, manufacture and commercialize biotherapeutics that address significant unmet medical needs. The company’s biotechnology focus is on oncology, immunology and tissue growth/repair disorders, but equally important to Genentech is its extensive work to include an emphasis on diversity in all interactions with employees, patients, and partners.

Genentech has developed several ways to incorporate cultural competency, including the support of health beliefs, practices, cultural and linguistic needs of diverse patient populations—into its every day work place and among employees.

“To fulfill our mission of developing important therapies for unmet medical needs and helping patients, we must continue to build an environment of full participation that allows us to draw on the knowledge and skills of each employee,” said Lisa M. Tealer,  Senior Diversity Manager at Genentech. “We gain invaluable resources from our employees, our partners, and our patients by harnessing their diversity of thought, style, culture, skill set, and perspective.”

Genentech’s diversity program houses several initiatives including Diversity Network Associations (DNA) —employee diversity groups such as African Americans in Biotechnology, Genentech Women Professionals, and VIDA Latino Professionals @ Genentech. DNA groups support community outreach efforts and serve as a conduit to diverse communities.

Another key to Genentech’s diversity outreach is partnership and support of key organizations aligned with their business. Genentech provided panelists for the CMA Foundation’s Network of Ethnic Physician Organizations (NEPO) Summit in 2007. The company will sponsor this year’s National Latino Cancer Summit—Latinas Contra Cancer, and supports the Sisters Network—an African American Breast Cancer Survivor Organization.

Genentech partners closely with its Community and Patient Program groups to help with various activities such as providing feedback on grant requests, and directing non-profit groups to apply for charitable giving aligned with its business and criteria.

To learn more about Genentech and its diversity programs and efforts, visit

back to top

6. Development Director Joins Foundation

The CMA Foundation is pleased to welcome a new development director to its team. Nicolette Bautista, MBA joined the Foundation in March, bringing with her 17 years of executive experience driving financial growth in the nonprofit arena.

Ms. Bautista most recently served as the CEO of WEAVE, Inc. in Sacramento where she led a successful turnaround of the organization that led to its receipt of the “Nonprofit Look of Success Award” from the Nonprofit Resource Center in 2006.

Prior to moving to Sacramento in 2002, Ms. Bautista helped raise $21 Million for an unprecedented public-private initiative in her hometown of Milwaukee, Wisconsin to reduce violent drug related crime and drug addiction.  She started her career in “the trenches” as a health worker and Peace Corps volunteer in West Central  Africa, and credits this experience with her chosen career.

“The issues the CMA Foundation addresses—such as antibiotic resistance awareness and obesity prevention, present very real, tangible threats to everyone’s well-being,” Bautista said. “To be part of a broad-based solution will be extremely rewarding.” 

In addition to serving on local and national boards, Ms. Bautista has owned three businesses, and speaks two languages. Her humanitarian efforts have been acknowledged in many publications including The Milwaukee Business Journal, with a “Top 40” Business Award, and as one of “20 Women We Admire” by Sacramento Magazine in 2004.

You can contact Nicolette Bautista at 916.551.2547.

Back to Top

Thank You to All of Our Generous Supporters!

Donor List: January 1, 2008 - April 15, 2008

1. Annual Dinner
2. Friends of the Foundation
3. General Contribution
4. Golf Classic
5. Holiday Letter
A. Gary F. Krieger, MD Memorial Fund
B. General Endowment Fund
C. Mahal Endowment Fund
D. Pacific Coast Funds
E. Physician Benevolence Fund
F. Robert D. Sparks, MD Endowment Fund
G. Steven M. Thompson Memorial Fund

Benefactors ($1,000+)

Genentech, Inc. (4)
Lia Margolis (B)
Pharmaceutical Research and Manufactures of America (PhRMA) (4)
Procter & Gamble Pharmaceuticals (4)
Dr. William and Debbie Ricks(3)
Robert Sparks, MD (F)
The Doctor's Company (4)
W.K. Kellogg Foundation (F)

Patrons ($500-$999)

Richard Frankenstein, MD (1)

Friends ($100-$499)

Chester Choi, MD (6)
Bulent Jajuli, MD (3)   
Los Angeles County Medical Association (1)
Ted Mazer, MD (3)
Marcy Zwelling-Aamot, MD (2) In honor of Franklin Lowe & Jacquelyn Vander Wall, MD

Supporters (up to $99)

Kent Adamson, MD (4)
Virgil Airola, MD (4)
Travis Calvin, MD (E)
Tom Curtis (4)
Eric Denys, MD (2)
James Dunn, MD (4)
Robert Faulk (4)
Tom Gaughan, PA (4)
Del Henninger, MD (4)
Thomas Johnson (4) 
Michael Ranahan, MD (4)
James Roach, MD (E)
  Richard Sun, MD (3)
Philip Verderame, MD (3)
Robert Wailes, MD (4)

Corporate Advisory Committee

Eli Lilly and Company
Kaiser Permanente
NORCAL Mutual Insurance Company

Abbott Laboratories
Blue Shield of California
Genentech, Incorporated
IMS Health
Pfizer, Inc.

Aetna, Inc.
AstraZeneca LP
Boehringer Ingelheim Pharmaceuticals
Bristol-Myers Squibb Company
DavisWrightTremaine, LLP
Endo Pharmaceuticals
Johnson & Johnson
L. A. Care Health Plan
Marriott California Business Council
McKesson Corporation
Miller Health Law Group
Nehemiah Corporation of America
Parker, Milliken, Clark, O’Hara & Samuelian, A Professional Corporation
Proctor and Gamble
Sankyo Pharmaceutical
Solvay Pharmaceuticals, Inc.
The Doctors’ Company

Leadership Circle

The Leadership Circle recognizes individuals who contributed $1,000 or more to the California Medical Association Foundation during the past year.

Frank Apgar, MD
Arthur Auer
Patricia Austin, MD
Richard Butcher, MD
Susan Bangasser
Theresa Caygill
Francis J. Crosson, MD & Sharon Levine, MD
David Der, MD
Martin Fishman, MD
Dr. & Mrs. David Holley
Shirley Howard, MD
Javad Jamshidi, MD
Carol A. Lee, Esq.
Dexter Louie, MD
Rolland Lowe, MD
Anmol S. Mahal, MD & Surjit K. Mahal, MD
Charles Maas, MD & Elissa Maas, MPH
Lia Margolis
J. Mario Molina, MD
Dr. & Mrs. Ralph Ocampo
William Ricks, MD
Joseph Scherger, MD
Lee Snook, MD
Robert Sparks, MD
Frank E. Staggers, Sr., MD
Satinder Swaroop, MD
Louis Vismara, MD

Cliff Walters, MD



© 2004 California Medical Association Foundation | Terms of Use
CMA Foundation
Sitemap Home